Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center pha
| Image |  |
|---|---|
| Description | scientific article published on 28 July 2020 |
| Author/s |
author: Owen A. O'Connor John Kuruvilla Helen Ma Diego Villa Enrica Marchi |
| Publication date | July 28, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |